𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis

✍ Scribed by S. Adami; J. San Martin; M. Muñoz-Torres; M. J. Econs; L. Xie; G. P. Dalsky; M. McClung; D. Felsenberg; J. P. Brown; M. L. Brandi; A. Sipos

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
187 KB
Volume
19
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of 1 year of daily teriparatide
Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate
✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t